Global Prevalence Rates by Nation
Analyzing annual prevalence—the proportion of a particular population found to be affected by a medical condition or characteristic at a specific time—provides critical insights into global health and social trends. By examining data across various nations and entities, we can identify geographic clusters and disparities in prevalence rates.
The following data represents a comprehensive collection of prevalence percentages recorded across different years and regions, including official national reports and estimates from the United Nations Office on Drugs and Crime (UNODC).
ไม่มีภาพประกอบ
Key Facts
- Afghanistan recorded the highest annual prevalence in this dataset at 3.65% (2015).
- Singapore recorded the lowest annual prevalence at 0.004% (2004).
- Several nations, including China, South Korea, and Japan, show prevalence rates of 0.2% or lower.
- Data sources include a mix of national surveys and UNODC estimates.
- The timeframes for these records span from 1995 to 2017.
Detailed Prevalence Analysis
High Prevalence Regions
Certain nations exhibit significantly higher prevalence rates compared to the global average. Afghanistan (3.65%) and Iran (3.31%) lead the list, both with data from 2015. Other nations with prevalence rates exceeding 1% include Russia (1.64%), the Maldives (1.34%), Ukraine (1.16%), Macau (1.1%), the United States (1.04%), Kazakhstan (1.03%), and Pakistan (1.00%).
Moderate Prevalence Trends
A large cluster of countries falls within the 0.4% to 0.9% range. This includes diverse economies such as Malaysia (0.94%), the United Kingdom (0.73%), Ireland (0.72%), and Italy (0.52%). In these regions, the prevalence is notably lower than in the high-prevalence group but remains a measurable demographic factor.
ไม่มีภาพประกอบ
Low Prevalence Observations
Many nations report prevalence rates of 0.2% or less. This group includes major global economies like China (0.2%), Brazil (0.1%), and Japan (0.1%). The lowest recorded figures are found in the Gulf region and Southeast Asia, with Saudi Arabia, Qatar, and Brunei Darussalam all reporting 0.01%, and Singapore reporting the minimum of 0.004%.
Comparative Data Summary
The table below summarizes the prevalence rates for a selection of nations across different continents and time periods.
| Country or Entity | Annual Prevalence (%) | Year | Notes |
|---|---|---|---|
| Afghanistan | 3.65 | 2015 | - |
| Iran | 3.31 | 2015 | - |
| United States of America | 1.04 | 2016 | - |
| United Kingdom | 0.73 | 2012 | - |
| Canada | 0.4 | 2000 | Ontario, 18+ (UNODC) |
| China | 0.2 | 2003 | - |
| Japan | 0.1 | 2002 | - |
| Singapore | 0.004 | 2004 | - |
Frequently Asked Questions
Which country has the highest reported prevalence?
Based on the provided data, Afghanistan has the highest annual prevalence at 3.65%, recorded in 2015.
Which country has the lowest reported prevalence?
Singapore has the lowest reported annual prevalence in the dataset at 0.004%, recorded in 2004.
What is the role of UNODC in this data?
The United Nations Office on Drugs and Crime (UNODC) provided estimates for several countries where direct national data may have been unavailable or required standardization, such as in the cases of Canada, Angola, and Taiwan.
Are there specific age groups mentioned in the data?
Yes, some entries specify age ranges. For example, Canada's data refers to individuals aged 18 and over in Ontario, Israel's data covers ages 18-65, and the Dominican Republic's data covers ages 12-70.
How does the prevalence in the US compare to other Western nations?
The United States (1.04% in 2016) shows a higher prevalence than the United Kingdom (0.73% in 2012), Canada (0.4% in 2000), and Germany (0.22% in 2014).